oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

VALZEK

Suspected exceedance of acceptable levels of NDMA and NDEA impurities in the active substance Valsartanum from the supplier Zhejiang Tianyu Pharmaceuticals; subsequent tests did not confirm limit exceedances. Potential effects: possible carcinogenic effects with long-term exposure.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

VALZEK
Risk Level
Medium
Manufacturer
Celon Pharma S.A.
Recall Date
06.06.2019
View official statement

Important Information

What You Should Know

Recommendations

Patients may continue to use Valzek 160 mg as prescribed; if in doubt, they should consult their doctor or pharmacist.

Actions Taken

Initially, all batches of Valzek 160 mg containing active substance from Zhejiang Tianyu Pharmaceuticals were suspended from the market (decision No. 49/WS/2018), and subsequently, after demonstrating...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: Suspected exceedance of acceptable levels of NDMA and NDEA impurities in the active substance Valsartanum from the supplier Zhejiang Tianyu Pharmaceuticals; subsequent tests did not confirm limit exceedances. Potential effects: possible carcinogenic effects with long-term exposure.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Check the official report for specific batch details.

Related

Other Recalled Products